After a median follow-up of 13.3 months (95% CI, 9.04-18.69), the median duration of response was 18.1 months, progression ...
Clinical measures and biomarkers during pregnancy, including hs-cTnI and sFlt-1, can help identify women at higher risk of developing cardiovascular disease later in life.
Introduction Hypertension programmes have expanded substantially in low-income and middle-income countries, yet treatment and control rates remain insufficient. Programme scale-up may lead to ...
Participants with three or more cerebral microbleeds of any pattern also had an increased risk of dementia (HR 1.92, 95% CI 1.35-2.72), as did peers with at least two subcortical microbleeds, ...
The data suggest significant challenges in maintaining long-term disease control with advanced systemic therapies for atopic dermatitis.
Older adults enrolled in a Medicare Advantage (MA) or Medicare-Medicaid dual-eligible plan were less likely to be discharged to highly rated post-acute care than those covered by traditional Medicare, ...
Background We describe the occurrence of second primary lung cancers (SPLCs) and their determinant in Sweden. Methods Nation-wide cancer registry from years 1961 to 2021 identified a total of 853 ...
A new Danish study compiles 10 years of research from one of the world's largest and most detailed puberty cohorts and points to three main conclusions: puberty is occurring earlier; genes, pregnancy ...
Objective Unplanned hospital readmissions within 30 days of discharge measure the quality of healthcare. This study aims to ...
MedPage Today on MSN
Better survival in refractory CRC with chemo plus bevacizumab, real-world study says
OS of 8.9 months versus 5.8 months with trifluridine/tipiracil alone, supporting phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results